Jagsonpal Pharmaceuticals informs about annual secretarial compliance report

01 Jul 2020 Evaluate

Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1//27/2019 dated February 8, 2019, Jagsonpal Pharmaceuticals has informed that it has enclosed the Annual Secretarial Compliance Report for the Financial Year ended 31st March, 2020.

The above information is a part of company’s filings submitted to BSE. 

Jagsonpal Pharma Share Price

193.65 0.70 (0.36%)
09-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.35
Dr. Reddys Lab 1212.35
Cipla 1224.25
Zydus Lifesciences 902.15
Lupin 2296.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×